Bain Capital Life Sciences Opportunities III GP, LLC — SEC Form 4 filings

SEC reporting owner CIK 1964467. 1 Form 4 filing on record with FilingPulse; latest filed 2024-02-14.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2024-02-14 to 2024-02-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kyverna Therapeutics, Inc. (KYTX)10% owner11 leg · 450,000 sh · $9,900,0002

Form 4 filings — Bain Capital Life Sciences Opportunities III GP, LLC

FiledFormIssuerReported transactionsSource
2024-02-144Kyverna Therapeutics, Inc. (KYTX)
jointly with Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences III General Partner, LLC, Bain Capital Life Sciences Fund III, L.P., Bain Capital Life Sciences Opportunities III, LP
Conversion (C): 2,713,868 · Purchase (P): 450,000 @ $22 · Conversion (C): 12,351,087 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1964467 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →